. Author manuscript; available in PMC: 2019 Dec 1.

Published in final edited form as: Eat Weight Disord. 2019 Jan 2;24(6):983–995. doi: 10.1007/s40519-018-0632-9

Table 4.

Group comparisons to test each effect

Main or interaction effect to evaluate	Comparison		% of total sample
Main or interaction effect to evaluate	Cells in Group 1	Cells in Group 2	% of total sample
OV	1, 2, 3, 4, 6, 7, 8, 12	5, 9, 10, 11, 13, 14, 15, 16	100
AR	1, 2, 3, 5, 6, 9, 10, 13	4, 7, 8, 11, 12, 14, 15, 16	100
ICT	1, 2, 4, 5, 7, 9, 11, 14	3, 6, 8, 10, 12, 13, 15, 16	100
ICT + Med	1, 4, 5, 6, 11, 12, 13, 16	2, 3, 7, 8, 9, 10, 14, 15	100
AR + Med	1, 3, 5, 7, 10, 12, 14, 16	2, 4, 6, 8, 9, 11, 13, 15	100
AR + ICT	1, 2, 5, 8, 9, 12, 15, 16	3, 4, 6, 7, 10, 11, 13, 14	100
OV + Med	1, 3, 4, 8, 9, 13, 14, 16	2, 5, 6, 7, 10, 11, 12, 15	100
OV + ICT	1, 2, 4, 7, 10, 13, 15, 16	3, 5, 6, 8, 9, 11, 12, 14	100
OV + AR	1, 2, 3, 6, 11, 14, 15, 16	4, 5, 7, 8, 9, 10, 12, 13	100
AR + ICT + Med	1, 5, 6, 7, 8, 13, 14, 15	2, 3, 4, 9, 10, 11, 12, 16	100
OV + ICT + Med	1, 4, 6, 9, 10, 12, 14, 15	2, 3, 5, 7, 8, 11, 13, 16	100
OV + AR + Med	1, 3, 7, 9, 11, 12, 13, 15	2, 4, 5, 6, 8, 10, 14, 16	100
OV + AR + ICT	1, 2, 8, 10, 11, 12, 13, 14	3, 4, 5, 6, 7, 9, 15, 16	100
OV + AR + ICT + Med	1, 6, 7, 8, 9, 10, 11, 16	2, 3, 4, 5, 12, 13, 14, 15	10%

RE self-monitoring and regular eating, OV reducing overvaluation of shape and weight, AR adaptive responses to cues, ICT inhibitory control training, Med anti-depressant medication